Spire Wealth Management’s MacroGenics MGNX Stock Holding History

Spire Wealth Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.07K	Hold	664	–	–	﹤0.01%	1919
2026 Q1	$1.92K	Hold	664	–	–	﹤0.01%	2050
2025 Q4	$1.07K	Hold	664	–	–	﹤0.01%	2188
2025 Q3	$1.12K	Hold	664	–	–	﹤0.01%	2256
2025 Q2	$803	Hold	664	–	–	﹤0.01%	2312
2025 Q1	$843	Hold	664	–	–	﹤0.01%	2410
2024 Q4	$2.16K	Hold	664	–	–	﹤0.01%	2238
2024 Q3	$2.19K	Hold	664	–	–	﹤0.01%	1991
2024 Q2	$2.82K	Hold	664	–	–	﹤0.01%	1946
2024 Q1	$9.77K	Buy	664 +50	+8%	+$756	﹤0.01%	1716
2023 Q4	$7.37K	Sell	614 -500	-45%	-$3.46K	﹤0.01%	1837
2023 Q3	$5.19K	Buy	+1,114	New	+$5.55K	﹤0.01%	1934
2022 Q2	–	Sell	-120	Closed	-$1K	–	2773
2022 Q1	$1K	Hold	120	–	–	﹤0.01%	2472
2021 Q4	$2K	Hold	120	–	–	﹤0.01%	2786
2021 Q3	$3K	Hold	120	–	–	﹤0.01%	2404
2021 Q2	$3K	Sell	120 -1,500	-93%	-$43.9K	﹤0.01%	2419
2021 Q1	$52K	Buy	+1,620	New	+$39.3K	﹤0.01%	1708

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Spire Wealth Management's MGNX Position: Q2 2026 in Review

Spire Wealth Management held its MacroGenics (MGNX) position steady in Q2 2026 at 664 shares worth $3.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Spire Wealth Management first reported a position in MGNX in Q1 2021 and has held it in 17 quarters since. The position peaked at $52K in Q1 2021. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Spire Wealth Management held 664 shares of MacroGenics worth $3.07K as of Q2 2026.
Spire Wealth Management left its MacroGenics share count unchanged in Q2 2026.
MacroGenics made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1919 holding.
Spire Wealth Management first reported a position in MacroGenics in Q1 2021 and has held it in 17 quarters since.
Spire Wealth Management's MacroGenics position peaked at $52K in Q1 2021.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.